Search alternatives:
significant model » significant amount (Expand Search), significant burden (Expand Search), significant gender (Expand Search)
larger decrease » marked decrease (Expand Search)
lower decrease » linear decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
significant model » significant amount (Expand Search), significant burden (Expand Search), significant gender (Expand Search)
larger decrease » marked decrease (Expand Search)
lower decrease » linear decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
1
-
2
-
3
Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.
Published 2024Subjects: -
4
-
5
Scenario analysis for daratumumab using a cumulative cost-based price per year per vial.
Published 2024Subjects: -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
Spike train replicability of CA1 pyramidal cell model with event-based input encoding.
Published 2023Subjects: -
20